Use of [177Lu]Lu-DOTA-TATE in the treatment of gastroenteropancreatic neuroendocrine tumours: Results of a UK cost-effectiveness modelling study

Aim: To evaluate the cost-effectiveness of [177Lu]Lu-DOTA-TATE versus relevant comparators for the treatment of neuroendocrine tumours located in the gastrointestinal tract (GI-NETs) and the pancreas (P-NETs). Materials and methods: A three-state partitioned survival model was developed to perform a...

Повний опис

Бібліографічні деталі

Автори:	Matthew Glover, Martyn Caplin, Oscar R. Leeuwenkamp, Louise Longworth
Формат:	Artigo
Мова:	Inglês
Опубліковано:	Elsevier 2021-11-01
Серія:	EJC Supplements
Предмети:	Gastro-enteropancreatic neuroendocrine tumours (GEP-NETs) 177Lu-DOTA-octreotate [177Lu]Lu-DOTA-TATE Everolimus Sunitinib Quality-Adjusted Life Years (QALYs)
Онлайн доступ:	http://www.sciencedirect.com/science/article/pii/S1359634921000033
Теги:	Додати тег Немає тегів, Будьте першим, хто поставить тег для цього запису!